Monthly Archives: October 2013

Update from London on the EACPT

The Executive Committee of the European Association for Clinical Pharmacology and Therapeutics (EACPT) met in London 12-13 October, hosted by the British Pharmacological Society. The main business of this EC meeting was planning for major pending events and activities. Key items included:

Members of the EACPT Executive Committee

the 12th biennial EACPT congress to be held from 27-29 June 2015 in Madrid – the EACPT focus meeting in Nijmegen in the Netherlands, 3-5 July 2014 – the key theme is cardiovascular.– update on the official EACPT journal Clinical Therapeutics (online access is a benefit for individual Associates of the EACPT – see register interest link below) – interaction with key policy organisations interested in medicines and patient safety, including the European Medicines Agency.…

EMA health professional working party elects EACPT’s Gonzalo Calvo as its first co-chair

Gonzalo Calvo, chair of the European Association for Clinical Pharmacology and Therapeutics(EACPT), is the new co-chair of the HCPWP of the European Medicines Agency
Professor Calvo is a consultant in clinical pharmacology in Barcelona and has extensive experience both in medicines regulation, including nearly ten years as member of the Agency’s Committee for Medicinal Products for Human Use (CHMP), and in learned societies.…

New European Medicines Agency advice on black triangle prompts for medicines monitoring

See full EMA Press Release

Adverse reactions to drugs and vaccine are common and may be serious, with the risk of leading to hospital admission, delayed discharge from hospital or death. It has been estimated that up to two-thirds of the ADRs may be preventable, or interrupted before they become severe. 
The European Medicines Agency (see press release link above) has introduced a new EU-wide scheme to improve reporting and prevention of new, unexpected and serious adverse reactions to drugs and vaccines.…

Skip to toolbar